Paul Wright MRPharmS, MSc, Sotiris Antoniou MRPharmS, MSc, DipMgt
{"title":"Ticagrelor: new antiplatelet for prevention of thrombotic events","authors":"Paul Wright MRPharmS, MSc, Sotiris Antoniou MRPharmS, MSc, DipMgt","doi":"10.1002/fps.75","DOIUrl":null,"url":null,"abstract":"<p><b>Antiplatelet drugs such as aspirin and clopidogrel are the cornerstone of atherothrombotic prevention in patients with ACS following percutaneous coronary intervention and coronary artery bypass grafting. However, due to variable response with these drugs many patients still experience atherothrombotic complications despite treatment. Ticagrelor (Brilique) reversibly and selectively inhibits adenosine diphosphate-mediated platelet activation. Because it does not require metabolic activation in the liver, it has rapid onset and is less likely to exhibit interpatient variability.</b></p>","PeriodicalId":100566,"journal":{"name":"Future Prescriber","volume":"12 1","pages":"14-16"},"PeriodicalIF":0.0000,"publicationDate":"2011-05-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1002/fps.75","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Future Prescriber","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/fps.75","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Antiplatelet drugs such as aspirin and clopidogrel are the cornerstone of atherothrombotic prevention in patients with ACS following percutaneous coronary intervention and coronary artery bypass grafting. However, due to variable response with these drugs many patients still experience atherothrombotic complications despite treatment. Ticagrelor (Brilique) reversibly and selectively inhibits adenosine diphosphate-mediated platelet activation. Because it does not require metabolic activation in the liver, it has rapid onset and is less likely to exhibit interpatient variability.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
